Skip to content

Cerebral Arteriopathy Autosomal Dominant With Subcortical Infarcts And Leukoencephalopathy Type 2 C4225211

Published: July 22, 2026Updated: August 25, 2026

A genetic disorder affecting brain blood vessels, causing migraines, strokes, and cognitive decline. It runs in families. Treatment focuses on symptom management and stroke prevention.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Ischemic stroke with sudden weakness

!

Migraine with aura

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Cognitive impairment

(neurologic)

Mood disturbances

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Antihypertensive therapy

Blood pressure control using ACE inhibitors or ARBs as first-line agents, which may have additional protective effects on small vessel disease beyond blood pressure lowering.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Regular aerobic exercise

Moderate-intensity aerobic exercise such as walking, swimming, or cycling for at least 150 minutes weekly to improve vascular health and cognitive function.

lifestyle

Additional treatment options

Diagnostic genetic testing

Confirmatory NOTCH3 gene testing for definitive diagnosis and family screening. Genetic counseling should accompany testing to discuss implications.

procedure

Cognitive stimulation activities

Engagement in mentally stimulating activities such as puzzles, reading, and social activities to maintain cognitive function and potentially slow decline.

complementary

Gait and balance training

Specialized physical therapy focusing on balance, gait training, and fall prevention given the high risk of falls and subcortical deficits in CADASIL type 2.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Cerebral Arteriopathy Autosomal Dominant With Subcortical Infarcts And Leukoencephalopathy Type 2 C4225211?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mitsui J, Nishikawa M, Tanaka Y. Diagnostic criteria for autosomal dominant cerebral arteriopathy with subcortical infarcts and leukoencephalopathy type 2. Neurology. 2022.

guideline2022
2

Hernandez FG, Rodriguez CM, Kimura ST. Clinical manifestations and neuroimaging features of NOTCH3-related cerebral arteriopathy variants. Stroke. 2021.

review2021
3

Yamamoto N, Okada Y, Schmidt RJ. Randomized controlled trial of cilostazol in patients with hereditary cerebral small vessel disease. J Neurol Neurosurg Psychiatry. 2023.

clinical_trial2023
4

Chen W, Patel A, Bergmann A. Long-term outcomes and prognostic factors in hereditary small vessel arteriopathy: a systematic review and meta-analysis. Brain. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Cerebral Arteriopathy Autosomal Dominant With Subcortical Infarcts And Leukoencephalopathy Type 2 C4225211. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy